Ductal carcinoma-in-situ: Long-term results of breast-conserving therapy Academic Article uri icon

Overview

MeSH Major

  • Breast Neoplasms
  • Carcinoma, Intraductal, Noninfiltrating
  • Mastectomy, Segmental

abstract

  • DCIS is a favorable disease with an excellent long-term survival. The locoregional recurrence rate in patients with DCIS treated with BCT is similar to that in patients with early-stage invasive breast cancer treated with BCT, but time to locoregional recurrence is significantly longer in patients with DCIS. In patients with DCIS treated with BCT, intense surveillance for locoregional recurrence needs to be maintained for the patient's lifetime.

publication date

  • January 2000

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1007/s10434-000-0656-y

PubMed ID

  • 11034242

Additional Document Info

start page

  • 656

end page

  • 64

volume

  • 7

number

  • 9